Fol. Biol. 2023, 69, 186-193
https://doi.org/10.14712/fb2023069050186
Astaxanthin Induces Apoptosis in Human Osteosarcoma MG-63 Cells
References
1. , M. N. M., Yazmin, H., Che Rahim, N. F. et al. (2018) Curcumin analog DK1 induces apoptosis in human osteosarcoma cells in vitro through mitochondria-dependent signaling pathway. Molecules 23, 75.
<https://doi.org/10.3390/molecules23010075>
2. , G., Yeon, S. C., Dong, S. K. et al. (2018) Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives. Acta Pharm. Sin. B 8, 862-880.
<https://doi.org/10.1016/j.apsb.2018.05.006>
3. , A., Torchinsky, A., Carp, H. et al. (1999) The role of apoptosis in normal and abnormal embryonic development. J. Assist. Reprod. Genet. 16, 512-519.
<https://doi.org/10.1023/A:1020541019347>
4. , S., Nielsen, M. E., Scapagnini, G. (2018) Astaxanthin in skin health, repair, and disease: a comprehensive review. Nutrients 10, 522.
<https://doi.org/10.3390/nu10040522>
5. , G., Kluck, R. M. (2009) Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis. J. Cell Sci. 122, 2801-2808.
<https://doi.org/10.1242/jcs.038166>
6. , J.-H., Yuan, L.-Y., Huang, R.-B. et al. (2014) Aspirin inhibits proliferation and induces apoptosis of multiple myeloma cells through regulation of Bcl-2 and Bax and suppression of VEGF. Eur. J. Haematol. 93, 329-339.
<https://doi.org/10.1111/ejh.12352>
7. , C. A., Diaz-Quintana, A., Gonzalez-Arzola, K. et al. (2018) Cytochrome c speeds up caspase cascade activation by blocking 14-3-3ε-dependent Apaf-1 inhibition. Cell Death Dis. 9, 365.
<https://doi.org/10.1038/s41419-018-0408-1>
8. , A. (2019) Mitochondria-targeting anticancer metal complexes. Curr. Med. Chem. 26, 694-728.
<https://doi.org/10.2174/0929867325666180307112029>
9. , S., Tao, H., Xia, K. (2020) Proscillaridin A induces apoptosis and inhibits the metastasis of osteosarcoma in vitro and in vivo. Biochem. Biophys. Res. Commun. 521, 880-886.
<https://doi.org/10.1016/j.bbrc.2019.11.012>
10. , I., Sinisgalli, C., Ostuni, A. et al. (2020) Astaxanthin anticancer effects are mediated through multiple molecular mechanisms: a systematic review. Pharmacol. Res. 155, 104689.
<https://doi.org/10.1016/j.phrs.2020.104689>
11. , S., Chen, X., Lo, H.-W. et al. (2019) Combined bazedoxifene and paclitaxel treatments inhibit cell viability, cell migration, colony formation, and tumor growth and induce apoptosis in breast cancer. Cancer Lett. 448, 11-19.
<https://doi.org/10.1016/j.canlet.2019.01.026>
12. , M., Huntley, M. E., Olaizola, M. (2003) Haematococcus astaxanthin: applications for human health and nutrition. Trends Biotechnol. 21, 210-216.
<https://doi.org/10.1016/S0167-7799(03)00078-7>
13. , K. M., Bhat, M. B., Wang, H. W. et al. (1999) Mitochondrial depolarization accompanies cytochrome c release during apoptosis in PC6 cells. J. Biol. Chem. 274, 5654-5658.
<https://doi.org/10.1074/jbc.274.9.5654>
14. , M. O. (2000) The biochemistry of apoptosis. Nature 407, 770-776.
<https://doi.org/10.1038/35037710>
15. , M. J., Patil, M. P., Jung, H. I. et al. (2019) Cristazine, a novel dioxopiperazine alkaloid, induces apoptosis via the death receptor pathway in A431 cells. Drug Dev. Res. 80, 504-512.
<https://doi.org/10.1002/ddr.21527>
16. , R. W., Ruefli, A. A., Lowe, S. W. (2002) Apoptosis: a link between cancer genetics and chemotherapy. Cell 108, 153-164.
<https://doi.org/10.1016/S0092-8674(02)00625-6>
17. , W.-S., Lee, K.-S., Kim, J.-H. et al. (2017) The caspase-8/Bid/cytochrome c axis links signals from death receptors to mitochondrial reactive oxygen species production. Free Radic. Biol. Med. 112, 567-577.
<https://doi.org/10.1016/j.freeradbiomed.2017.09.001>
18. , L., Fan, J., Ai, G. et al. (2019) Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells. Biol. Res. 52, 37.
<https://doi.org/10.1186/s40659-019-0243-6>
19. , P., Mortier, L., Beauvillain, V. et al. (2002) Are mithochondria direct targets of anticancer drugs responsible for apoptosis? Ann. Biol. Clin. (Paris) 60, 391-403.
20. , R., Murray, D. (2020) Intratumor heterogeneity and therapy resistance: contributions of dormancy, apoptosis reversal (anastasis) and cell fusion to disease recurrence. Int. J. Mol. Sci. 21, 1308.
<https://doi.org/10.3390/ijms21041308>
21. , L., Shi, Z., Zhao, S. et al. (2012) Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 45, 487-498.
<https://doi.org/10.1111/j.1365-2184.2012.00845.x>
22. , M., Biswal, B. K. (2019) Cell signaling and cancer: a mechanistic insight into drug resistance. Mol. Biol. Rep. 46, 5645-5659.
<https://doi.org/10.1007/s11033-019-04958-6>
23. , R., Callaway, D., Vanegas, D. et al. (2014) Caspase-2 maintains bone homeostasis by inducing apoptosis of oxidatively-damaged osteoclasts. PLoS One 9, e93696.
<https://doi.org/10.1371/journal.pone.0093696>
24. , Y. G. (2002) Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell 9, 459-470.
<https://doi.org/10.1016/S1097-2765(02)00482-3>
25. , Y., Zhang, H. Qin, Y. et al. (2018) Overcoming drug-resistant lung cancer by paclitaxel-loaded hyaluronic acid-coated liposomes targeted to mitochondria. Drug Dev. Ind. Pharm. 44, 2071-2082.
<https://doi.org/10.1080/03639045.2018.1512613>
26. , F., Artaria, C. (2017) Astaxanthin in cardiovascular health and disease: mechanisms of action, therapeutic merits, and knowledge gaps. Food Funct. 8, 39-63.
<https://doi.org/10.1039/C6FO01721E>
27. , M. L., Laussmann, M. A., Rehm, M. (2012) The central role of initiator caspase-9 in apoptosis signal transduction and the regulation of its activation and activity on the apoptosome. Exp. Cell Res. 318, 1213-1220.
<https://doi.org/10.1016/j.yexcr.2012.02.013>
